Tuberculin skin test to estimate the prevalence of Mycobacterium tuberculosis infection in indigenous populations in the Americas: A literature review;Teste tuberculínico na estimativa da prevalência de infecção por Mycobacterium tuberculosis em populações indígenas do continente americano: Uma revisão da literatura

Cadernos de Saude Publica

Volumn 22, Issue 2, 2006, Pages 245-254

  Basta, Paulo Cesar ^a   Camacho, Luiz Antonio Bastos ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

North American Indians; South American Indians; Tuberculin Test; Tuberculosis

Indexed keywords

EID: 33646241503     PISSN: 0102311X     EISSN: 16784464     Source Type: Journal    
DOI: 10.1590/s0102-311x2006000200002     Document Type: Review

References (55)

1. Prat JG, Souza SMFM. Prehistoric tuberculosis in America: adding comments to a literature review. Mem Inst Oswaldo Cruz 2003; 98 Suppl 1:151-9.
2. Black F. Infectious diseases in primitive societies. Science 1975; 187:515-8.
3. Gryzbowski S, Styblo K, Dorken E. Tuberculosis in Eskimos. Tubercle 1976; 57:S1-58.
4. Ribeiro D. Os índios e a civilização. Petrópolis: Editora Vozes; 1977.
5. Rieder HL. Tuberculosis among American Indians of the contiguous United States. Public Health Rep 1989; 104:653-7.
6. Tempest P, Pesanti E. A community-wide tuberculosis case finding program on the Navajo Reservation. Am Rev Respir Dis 1974; 110:760-4.
7. Enarson DA, Grzybowski S. Incidence of active tuberculosis in the native population of Canada. Can Med Assoc J 1986; 134:1149-52.
8. Young TK, Casson RI. The decline and persistence of tuberculosis in a Canadian Indian population: implications for control. Can J Public Health 1988; 79:302-6.
9. Enarson DA. Tuberculosis in Aboriginals in Canada. Int J Tuberc Lung Dis 1998; 2:S16-22.
10. Gryzbowski S, Allen EA. Tuberculosis: 2. History of the disease in Canada. Can Med Assoc J 1999; 160:1025-8.
11. Smeja C, Brassard P. Tuberculosis infection in an aboriginal (first nations) population of Canada. Int J Tuberc Lung Dis 2000; 4:925-30.
12. Nguyen D, Proulx JF, Westley J, Thilbert L, Dery S, Behr MA. Tuberculosis in the Inuit community of Quebec, Canada. Am J Respir Crit Care Med 2003; 168:1353-7.
13. Basta PC, Coimbra Jr. CEA, Escobar AL, Santos RV. Aspectos epidemiológicos da tuberculose na população indígena Suruí, Amazônia, Brasil. Rev Soc Bras Med Trop 2004; 37:338-42.
14. González N, Cubeddu LD, Waard JH, Fandiño C, Fernández-de Larrea C, López D, et al. Estudio de la respuesta immunitaria en niños Warao de comunidades con alta prevalencia de tuberculosis. Invest Clin 2003; 44:308-18.
15. Garnelo L, Macedo G, Brandão LC. Os povos indígenas e a construção das políticas de saúde no Brasil. Brasília: Organização Pan-Americana da Saúde; 2003.
16. Hurtado AM, Hill KR, Rosenblatt W, Bender J, Scharmen T. Longitudinal study of tuberculosis outcomes among immunologically naive Aché natives of Paraguay. Am J Phys Anthropol 2003; 121:134-50.
17. Santos RV, Coimbra Jr. CEA. Cenários e tendências da saúde e da epidemiologia dos povos indígenas no Brasil. In: Coimbra Jr. CEA, Santos RV, Escobar AL organizadores, Epidemiologia e saúde dos povos indígenas no Brasil. Rio de Janeiro: Editora Fiocruz; 2003. p. 13-48.
18. Escobar AL, Coimbra Jr. CEA, Camacho LAB, Portela MC. Tuberculose em populações indígenas de Rondônia, Amazônia, Brasil. Cad Saúde Pública 2001; 17:285-98.
19. Baruzzi RG, Barros VL, Rodrigues D, Souza ALM, Pagliaro H. Saúde e doença em índios Panará (Kreen-Akarôre) após vinte e cinco anos de contato com o nosso mundo, com ênfase na ocorrência de tuberculose (Brasil Central). Cad Saúde Pública 2001; 17:407-12.
20. Young TK, Mirdad S. Determinants of tuberculin sensitivity in a child population covered by mass BCG vaccination. Tuber Lung Dis 1992; 73:94-100.
21. Amarante JM, Costa VLA. A tuberculose nas comunidades indígenas brasileiras na virada do século. Bol Pneumol Sanit 2000; 8:5-12.
22. Snider Jr. DE. The tuberculin skin test. Am Rev Respir Dis 1982; 125:108-18.
23. Arnadotir T, Rieder HL, Trébucq A, Waaler HT. Guidelines for conducting tuberculin skin test survey in high prevalence countries. Tuber Lung Dis 1996; 77 Suppl:1-20.
24. Joncas JH, Robitaille R, Gauthier T. Interpretation of the PPD skin test in BCG-vaccinated children. Can Med Assoc J 1975; 26:127-8.
25. ten Dam HG, Hytze KL. Determining the prevalence of tuberculosis in populations with non-specific tuberculin sensitivity. Bull World Health Organ 1980; 58:475-83.
26. Camacho LAB, Klein CH. Risco de infecção tuberculosa entre escolares com alta cobertura vacinal pelo BCG. Bol Oficina Sanit Panam 1990; 108:101-12.
27. Arantes GR, Nardy SMC, Weiler RMG, Belluomini M, Nogueira PA. Estimativa do risco de infecção tuberculosa em populações vacinadas pelo BCG. Rev Saúde Pública 1992; 26:96-107.
28. Tala-Hiekkilä M, Nurmela T, Misljenovic O, Bleiker MA, Tala E. Sensitivity to PPD tuberculin and M. scrofulaceum sensitin in schoolchildren BCG vaccinated at birth. Tuber Lung Dis 1992; 73:87-93.
29. Rieder HL. Methodological issues in the estimation of the tuberculosis problem from tuberculin surveys. Tuber Lung Dis 1995; 76:114-21.
30. Singh D, Sutton C, Woodcock A. Repeat tuberculin testing in BCG-vaccinated subjects in the United Kingdom: the booster effect varies with the time of reading. Am J Respir Crit Care Med 2001; 164:962-4.
31. Neuenschwander BE, Zwahlen M, Kim SJ, Lee EG, Rieder HL. Determination of the prevalence of infection with Mycobacterium tuberculosis among persons vaccinated against Bacillus Calmette-Guéerin in South Korea. Am J Epidemiol 2002; 155:654-63.
32. Bierrenbach AL, Cunha SS, Barreto ML, Pereira SM, Dourado I, Ichihara MY, et al. Tuberculin reactivity in a population of schoolchildren with high BCG vaccination coverage. Rev Panam Salud Pública 2003; 13:285-93.
33. Albuquerque MFPM, Ximenes RAA, Campelo ARL, Sarinho E, Cruz M, Maia Filho V. Neonatal BCG vaccine and response to the tuberculin test in BCG vaccinated children in contact with tuberculosis patients in Recife, Brazil. J Trop Pediatr 2004; 50:32-6.
34. Sutherland I. On the risk of infection. Bull Int Union Tuber Lung Dis 1991; 66:189-91.
35. Sutherland I. Recent studies in the epidemiology of tuberculosis, based on the risk of being infected with tubercle bacilli. Adv Tuberc Res 1976; 19:1-63.
36. Styblo K. Surveillance of tuberculosis. Int J Epidemiol 1976; 5:63-8.
37. Cauthen GM, Pio A, ten Dam HG. Annual risk tuberculosis infection. Bull World Health Organ 2002; 80:503-20.
38. Araujo Z, Waard JH, Fernández-de Larrea C, López D, Fandiño C, Maldonado A, et al. Study of the antibody response against Mycobacterium tuberculosis antigens in Warao Amerindian children in Venezuela. Mem Inst Oswaldo Cruz 2004; 99:517-24.
39. Clark M, Vynnycky E. The use of maximum likelihood methods to estimate the risk of tuberculosis infection and disease in a Canadian first nations population. Int J Epidemiol 2004; 33:477-84.
40. Amarante JM, Costa VLA, Monteiro J. O controle da tuberculose entre os índios Yanomami do alto Rio Negro. Bol Pneumol Sanit 2003; 11:5-12.
41. Skotniski EM. Post-BCG tuberculin testing: interpreting results and establishing essential baseline data. Can J Public Health 1993; 84:307-8.
42. Menzies R, Vissandje B. Effect of Bacille Calmette-Guérin vaccination on tuberculin reactivity. Am Rev Respir Dis 1992; 145:621-5.
43. Lifschitz M. The value of the tuberculin skin test as a screening test for tuberculosis among BCG-vaccinated children. Pediatrics 1965; 36:624-7.
44. Escobar AL, Coimbra Jr. CEA, Camacho LA, Santos RV. Tuberculin reactivity and tuberculosis epidemiology in the Paakanova (Wari') Indians of Rondônia, Southwestern Brazilian Amazon. Int J Tuber Lung Dis 2004; 8:45-51.
45. Wang L, Turner MO, Elwood RK, Schulzer M, Fitzgerald JM. A meta-analysis of the effect of Bacille Calmette Guérin vaccination on tuberculin skin test measurements. Thorax 2002; 57:804-9.
46. Soborg, C, Madsen HO, Andersen, AB, Lillebaek T, Kok-Jensen A, Garred P. Mannose-binding lectin polymorphisms in clinical tuberculosis. J Infect Dis 2003; 188:777-82.
47. Greenwood CMT, Fujiwara TM, Boothroyd LJ, Miller MA, Frappier D, Fanning EA, et al. Linkage of tuberculosis to chromosome 2q35 loci, including NRAMP1, in a large aboriginal Canadian family. Am J Hum Genet 2000; 67:405-16.
48. Sousa AO, Salem JI, Lee FK, Verçosa MC, Cruaud P, Bloom BR, et al. An epidemic of tuberculosis with a high rate of tuberculin anergy among a population previously unexposed to tuberculosis, the Yanomami Indians of the Brazilian Amazon. Proc Natl Acad Sci USA 1997; 94:13227-32.
49. Gryzbowski S, Galbraith JD, Dorken E. Chemoprophylaxis tial in Canadian Eskimos. Tubercle 1976; 57:263-9.
50. Dorken E, Grzybowski S, Enarson DA. Ten year evaluation of a trial of chemoprophylaxis against tuberculosis in Frobisher Bay, Canada. Tubercle 1984; 65:93-9.
51. Larrabee WF, Tavalera R. Comparative skin testing in the Cuna Indians of Panama. Trop Geogr Med 1981; 33:335-8.
52. Amarante JM, Porto JF, Silva FA. Controle da tuberculose em área indígena. Experiência de uma nova abordagem em Água Branca - MT, maio de 1996. Rev Saúde Dist Fed 1996; 7:25-32.
53. Amarante JM, Costa VLA, Silva FA. Sensibilidade tuberculínica e vacina BCG entre os índios do Araguaia - MT, 1997. Bol Pneumol Sanit 1999; 7:79-86.
54. van Crevel R, van Doorninck DJ, van Ams JE, Fat HT, Vreden SG, van der Meer JM. Tuberculosis among Trio-Indians in Surinam. Ned Tijdschr Geneeskd 2004; 148:425-9.
55. Zarza NMH, Castillo LS, Castillo RO, Cruz AG. La técnica de Mantoux en población indígena. Caso de estudio. Rev Inst Nac Enfermedades Respir 2004; 17:73-9.